Drug intelligence / Profile preview

microRNA-98-5p mimic

Development stage
Preclinical
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
In Vitro Transfection, In Vitro Electroporation, Systemic Injection
01

Overview

microRNA-98-5p mimic is a synthetic double-stranded RNA oligonucleotide designed to emulate the biological activity of the endogenous tumor-suppressive microRNA, miR-98-5p. In non-small cell lung cancer (NSCLC), miR-98-5p expression is frequently downregulated, leading to the overexpression of its oncogenic targets. The mimic functions by binding to the 3'-untranslated region (UTR) of specific messenger RNAs, notably mitogen-activated protein kinase kinase kinase kinase 3 (MAP4K3) and insulin-like growth factor 2 (IGF2), thereby inducing their degradation or inhibiting their translation. Downregulation of MAP4K3 subsequently suppresses the mTOR signaling pathway, resulting in inhibited cell proliferation and induced apoptosis. Additionally, the mimic can restore sensitivity to chemotherapeutic agents like paclitaxel by counteracting the effects of circular RNAs (such as hsa_circ_0003489) that sponge endogenous miR-98-5p.

Other names
miR-98-5p mimicmiR98-5p mimicmiR 98-5p mimichsa-miR-98-5p mimichsa-miR98-5p mimichsa-miR 98-5p mimicmicroRNA-98 mimicmicroRNA98 mimicmicroRNA 98 mimic
02

Targets

MAP4K (MAP4K family)MAP4K4 (Mitogen-activated protein kinase kinase kinase kinase 4)IGF2BP1IGF2 (Insulin-like growth factor 2)TGFBR1FZD (Frizzled receptor family)

Beyond the preview

Go deeper on microRNA-98-5p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-98-5p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call